相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
Daniel J. Brat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing
Joshua M. Francis et al.
CANCER DISCOVERY (2014)
Tyrosine Phosphorylation of Mig6 Reduces Its Inhibition of the Epidermal Growth Factor Receptor
Zhihong Wang et al.
ACS CHEMICAL BIOLOGY (2013)
Cetuximab Response of Lung Cancer-Derived EGF Receptor Mutants Is Associated with Asymmetric Dimerization
Jeonghee Cho et al.
CANCER RESEARCH (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Pan-cancer patterns of somatic copy number alteration
Travis I. Zack et al.
NATURE GENETICS (2013)
The quest to overcome resistance to EGFR-targeted therapies in cancer
Curtis R. Chong et al.
NATURE MEDICINE (2013)
TARGETED THERAPIES Afatinib-new therapy option for EGFR-mutant lung cancer
Helena A. Yu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Mechanism for activation of mutated epidermal growth factor receptors in lung cancer
Monica Red Brewer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer
Hiroyuki Yasuda et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Mig6 Is a Sensor of EGF Receptor Inactivation that Directly Activates c-Abl to Induce Apoptosis during Epithelial Homeostasis
Sarah Hopkins et al.
DEVELOPMENTAL CELL (2012)
Glioblastoma-Derived Epidermal Growth Factor Receptor Carboxyl-Terminal Deletion Mutants Are Transforming and Are Sensitive to EGFR-Directed Therapies
Jeonghee Cho et al.
CANCER RESEARCH (2011)
Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors
Oreste Segatto et al.
JOURNAL OF CELL SCIENCE (2011)
Mechanistic insights into the activation of oncogenic forms of EGF receptor
Zhihong Wang et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2011)
Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma
Chetan Bettegowda et al.
SCIENCE (2011)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation
Yuri Frosi et al.
JOURNAL OF CELL BIOLOGY (2010)
Mig-6 controls EGFR trafficking and suppresses gliomagenesis
Haoqiang Ying et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Magnetic Bead Processor for Rapid Evaluation and Optimization of Parameters for Phosphopeptide Enrichment
Scott B. Ficarro et al.
ANALYTICAL CHEMISTRY (2009)
Improved Electrospray Ionization Efficiency Compensates for Diminished Chromatographic Resolution and Enables Proteomics Analysis of Tyrosine Signaling in Embryonic Stem Cells
Scott B. Ficarro et al.
ANALYTICAL CHEMISTRY (2009)
multiplierz: an extensible API based desktop environment for proteomics data analysis
Jignesh R. Parikh et al.
BMC BIOINFORMATICS (2009)
Negative Regulation of the EGFR-MAPK Cascade by Actin-MAL-Mediated Mig6/Errfi-1 Induction
Arnaud Descot et al.
MOLECULAR CELL (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The quest for the 1p36 tumor suppressor
Anindya Bagchi et al.
CANCER RESEARCH (2008)
Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS
Udayan Guha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Signaling networks assembled by oncogenic EGFR and c-Met
Ailan Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The evolutionarily conserved EBR module of RALT/MIG6 mediates suppression of the EGFR catalytic activity
S. Anastasi et al.
ONCOGENE (2007)
Constraint and turnover in sex-biased gene expression in the genus Drosophila
Yu Zhang et al.
NATURE (2007)
Allele-dependent variation in the relative cellular potency of distinct EGFR inhibitors
Yuki Yuza et al.
CANCER BIOLOGY & THERAPY (2007)
Activated Cdc42-associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradation
Feng Shen et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Structures of lung cancer-derived EGFR mutants and inhibitor complexes: Mechanism of activation and insights into differential inhibitor sensitivity
Cai-Hong Yun et al.
CANCER CELL (2007)
Mig-6, signal transduction, stress response and cancer
Yu-Wen Zhang et al.
CELL CYCLE (2007)
Evidence that MIG-6 is a tumor-suppressor gene
Y-W Zhang et al.
ONCOGENE (2007)
Epidermal growth factor receptor mutations in lung cancer
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2007)
Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain
Jeffrey C. Lee et al.
PLOS MEDICINE (2006)
Protein tyrosine kinase-substrate interactions
Ron Bose et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2006)
Activation of the nonreceptor protein tyrosine kinase Ack by multiple extracellular stimuli
Maria L. Galisteo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mig6 is a negative regulator of EGF receptor-mediated skin morphogenesis and tumor formation
Ingvar Ferby et al.
NATURE MEDICINE (2006)
Effects of HER2 overexpression on cell signaling networks governing proliferation and migration
Alejandro Wolf-Yadlin et al.
MOLECULAR SYSTEMS BIOLOGY (2006)
Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants
H Greulich et al.
PLOS MEDICINE (2005)
Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin
S Anastasi et al.
ONCOGENE (2005)
Gene 33 is an endogenous inhibitor of epidermal growth factor (EGF) receptor signaling and mediates dexamethasone-induced suppression of EGF function
DZ Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Feedback inhibition by RALT controls signal output by the ErbB network
S Anastasi et al.
ONCOGENE (2003)
Multiparametric scaling of diffraction intensities
Z Otwinowski et al.
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2003)
Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control
M Fiorini et al.
ONCOGENE (2002)
Mig-6 is a negative regulator of the epidermal growth factor receptor signal
PO Hackel et al.
BIOLOGICAL CHEMISTRY (2001)
Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain
L Fiorentino et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Gene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK - A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stress
A Makkinje et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
